Skip to main content

Vertex’s stock heads for all-time high as non-opioid painkiller shows promise

Vertex Pharmaceuticals' stock was on track for an all-time high Wednesday after the company released new data on its experimental non-opioid pain medicine.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.